Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-02-18 @ 1:55 PM
Study NCT ID:
NCT05815758
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2023-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
Sponsor:
Bausch & Lomb Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Allergic Conjunctivitis | View |
Keywords: